Satsuma Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Satsuma Pharmaceuticals

09/08/2022 23:30

* Satsuma Pharmaceuticals Inc  STSA.OQ  reported a quarterly
adjusted loss of 52 cents​​ per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of 49 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Satsuma Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 52 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Satsuma Pharmaceuticals Inc shares had risen by 35.7% this
quarter and gained 24.9% so far this year.
    * The company reported a quarterly loss of $16.27 million.
    * Wall Street's median 12-month price target for Satsuma
Pharmaceuticals Inc is $13.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 10:30 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.49          -0.52          Missed
 Mar. 31 2022      -0.49          -0.49          Met
 Dec. 31 2021      -0.48          -0.49          Missed
 Sep. 30 2021      -0.51          -0.42          Beat